The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-N,N-dimethyl-1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-imidazo[4,5-c]quinoline ID: ALA4874356
PubChem CID: 66571468
Max Phase: Preclinical
Molecular Formula: C24H29N5O3
Molecular Weight: 435.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(cc1-c1c(C)noc1C)ncc1nc(N(C)C)n(CC3CCOCC3)c12
Standard InChI: InChI=1S/C24H29N5O3/c1-14-22(15(2)32-27-14)18-10-19-17(11-21(18)30-5)23-20(12-25-19)26-24(28(3)4)29(23)13-16-6-8-31-9-7-16/h10-12,16H,6-9,13H2,1-5H3
Standard InChI Key: HCEZPGCCFZDDQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
2.4986 -25.5505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4975 -26.3780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2123 -26.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2105 -25.1378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9259 -25.5469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9267 -26.3737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6419 -26.7847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3570 -26.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6364 -25.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3489 -25.5410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9574 -24.9895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6209 -24.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8045 -24.3289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2503 -23.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7840 -25.1382 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7838 -24.3132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7826 -26.7899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0320 -26.4570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4794 -27.0697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8914 -27.7846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6984 -27.6136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8601 -25.6502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3121 -28.1649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5027 -22.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3084 -22.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5615 -21.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0103 -21.3671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2025 -21.5397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9459 -22.3265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0310 -23.5244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8560 -23.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9135 -22.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 10 1 0
9 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
13 14 1 0
1 15 1 0
15 16 1 0
2 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 17 2 0
18 22 1 0
21 23 1 0
14 24 1 0
24 25 1 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
12 30 1 0
30 31 1 0
30 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.53Molecular Weight (Monoisotopic): 435.2270AlogP: 4.36#Rotatable Bonds: 5Polar Surface Area: 78.44Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.46CX LogP: 3.04CX LogD: 3.04Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.46Np Likeness Score: -0.89
References 1. Jones KL, Beaumont DM, Bernard SG, Bit RA, Campbell SP, Chung CW, Cutler L, Demont EH, Dennis K, Gordon L, Gray JR, Haase MV, Lewis AJ, McCleary S, Mitchell DJ, Moore SM, Parr N, Robb OJ, Smithers N, Soden PE, Suckling CJ, Taylor S, Walker AL, Watson RJ, Prinjha RK.. (2021) Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression., 64 (16.0): [PMID:34387088 ] [10.1021/acs.jmedchem.1c00855 ]